Docetaxel (Taxotere) and gemcitabine in combination therapy

Seminars in Oncology

Volumn 26, Issue 3 SUPPL. 11, 1999, Pages 19-22

  Rizvi, N A ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCETAXEL; GEMCITABINE;

ADJUVANT CHEMOTHERAPY; ADULT; ADVANCED CANCER; ASTHENIA; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MIXTURE; DRUG TOLERABILITY; EDEMA; FLU LIKE SYNDROME; HUMAN; LUNG NON SMALL CELL CANCER; META ANALYSIS; NEUTROPENIA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIALS, PHASE I; CLINICAL TRIALS, PHASE II; DEOXYCYTIDINE; HUMANS; LUNG NEOPLASMS; PACLITAXEL; TAXOIDS;

EID: 0032866187     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)